Indonesia’s West Java to be completely protected by comprehensive smokefree policies
All twenty-seven cities and districts in West Java, Indonesia’s most densely populated region, now prohibit smoking in all public places…
7-1-7: Improving our response to tuberculosis
The Union and international partners are exploring whether the detection and control of tuberculosis (TB) can be improved using the “7-1…
The Union announces new TB Department Director
The Union is delighted to announce that Dr Kobto Koura has been appointed as the Director of the Department of Tuberculosis.
…
The importance of localised programmes and tailored training to tackle TB infection
Dr. Nacho Monedero shares his views on importance of localised programmes, why governments need to continue investing and his experiences travelling the world to further our mission to end TB.
The IJTLD: the story continues
An Editorial in the IJTLD explains the increase in the Journal's impact factor and describes how we are improving the Journal for authors and readers. The preprint is free to read.
The IJTLD: the story continues
An Editorial in the IJTLD explains the increase in the Journal's impact factor and describes how we are improving the Journal for authors and readers. The preprint is free to read.
PHILIPPINES RESTORES THE FDA AND DOH’S AUTHORITY TO REGULATE TOBACCO PRODUCTS
After a 11-year battle, the Philippines’ Supreme Court ruled to uphold the authority of the Food and Drug Administration (FDA) and the Department of Health (DOH) to regulate all products affecting health, including tobacco products. This reverses a 2011 petition filed by the Philippine Tobacco Institute—its members include Philip Morris Philippines Manufacturing, Inc., Fortune Tobacco Corp., La Suerte Cigar, and Cigarette Factory—to prevent tobacco products regulation by the FDA and DOH.
The impact of COVID-19 on TB control for vulnerable groups
Z. Aranda and H. J. Sánchez-Pérez call on health providers, researchers and decision-makers to develop studies and interventions that address the impact of COVID-19 on TB control in vulnerable populations.
The impact of COVID-19 on TB control for vulnerable groups
Z. Aranda and H. J. Sánchez-Pérez call on health providers, researchers and decision-makers to develop studies and interventions that address the impact of COVID-19 on TB control in vulnerable populations.
Farewell Don Enarson
The Union is very sad to learn that Don Enarson, our first full-time Director of Scientific Activities, died on Wednesday. Don joined…
WHO awards President of Mexico with 2022 World No Tobacco Day special prize for outstanding tobacco control progress
On 31 May, the President of México, the Honorable Andrés Manuel López Obrador received special recognition from the World Health…
Professeur Badoum et Docteur Koura nous parlent de la rapide communication de l’OMS sur le traitement de la TB multirésistante
Professeur Gisèle Badoum, Consultante à l’Union International contre la Tuberculose et les Maladies Respiratoires et…
Treatment of Multidrug-Resistant Tuberculosis: The latest guidance from WHO
Treatment of multidrug-resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) is difficult. Dr Chen-Yuan Chiang, Senior Consultant at The Union, discusses the World Health Organization's latest rapid communication.
Progress on indoor air quality regulation in India
The power of the pen - Correspondence in a forthcoming issue of the IJTLD highlights how a Letter to the Editor helped to progress legislation on indoor air quality in India. The preprint is free to read.
Progress on indoor air quality regulation in India
The power of the pen - Correspondence in a forthcoming issue of the IJTLD highlights how a Letter to the Editor helped to progress legislation on indoor air quality in India. The preprint is free to read.
World Health Assembly – commit to TB research and innovation
The 75th session of the World Health Assembly takes place this week in Geneva. The International Union Against Tuberculosis and Lung…
WHO drug-resistant TB guidelines 2022: what is new?
An Editorial in a forthcoming issue of the IJTLD examines the WHO's recent rapid communication on key changes to the treatment of drug-resistant TB. The preprint is free to read.
WHO drug-resistant TB guidelines 2022: what is new?
An Editorial in a forthcoming issue of the IJTLD examines the WHO's recent rapid communication on key changes to the treatment of drug-resistant TB. The preprint is free to read.
International Nurses Day 2022
On International Nurses Day 2022, The Union would like to celebrate and acknowledge the outstanding contributions of nurses to end…
Supporting the next generation: Student nurse members
As part of a drive to support the next generation of lung health leaders, The Union is accepting applications for free student…
Expression of interest: new members of the Union Ethics Advisory Group
The Ethics Advisory Group (EAG) of the International Union Against Tuberculosis and Lung Disease is seeking one or more new members.…
The Asthma Drug Facility and the future management of asthma
An Editorial in the next issue of the IJTLD examines lessons learned from the Asthma Drug Facility and how this informs future plans for asthma management. The preprint is free to read.
The Asthma Drug Facility and the future management of asthma
An Editorial in the next issue of the IJTLD examines lessons learned from the Asthma Drug Facility and how this informs future plans for asthma management. The preprint is free to read.
Union research features in WHO COVID-19 success stories report
A research project undertaken by The Union has featured in the WHO’s second report of country success stories in mitigating the impact…
Invest in tobacco control to end tuberculosis in Indonesia
Over 61.4 million people in Indonesia smoke, with 65% of all adult men smoking. In 2020, the Joint External Monitoring Mission on…
The Union
subtitle: International Union Against Tuberculosis and Lung Disease